With an estimated 28 million new cancer diagnoses expected worldwide each year by 20401, we know we must strive to maximize the impact of our treatments and pioneer novel medicines. Our work in oncology is driven by the belief that we can improve the futures of people living with cancer. Our science of cancer is opening up new possibilities and sparking discovery to explore the full potential of promising mechanisms.
BAVENCIO® (avelumab) Injection 20mg/mL
Learn about our key disease areas and more:
Press Releases
The company today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor
2025/10/17
Press Releases
The company today announced the presentation of detailed positive results from Part 1 of the global Phase 3 MANEUVER trial evaluating pimicotinib
2025/05/28
Press Releases
The company today announced the presentation of new oncology data across more than 12 tumor types at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.
2025/05/22
1 American Cancer Society. What Is Lung Cancer? Available at: https://www.cancer.org/cancer/lung-cancer/about/what-is.html. Accessed May 3, 2021.
